Greenlight Capital Q1 2022 holdings

$1.57 Billion is the total value of Greenlight Capital's 154 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 0.0% .

 Value Shares↓ Weighting
GPN  GLOBAL PMTS INC$69,241
+1.2%
506,0000.0%4.40%
+12.4%
SLV  ISHARES SILVER TRishares$35,647
+6.4%
1,558,0000.0%2.26%
+18.2%
GPK  GRAPHIC PACKAGING HLDG CO$16,679
+2.8%
832,2700.0%1.06%
+14.2%
INTC  INTEL CORP$15,338
-3.8%
309,5000.0%0.98%
+6.9%
NWS  NEWS CORP NEWcl b$8,136
+0.1%
361,2910.0%0.52%
+11.2%
NBSE  NEUBASE THERAPEUTICS INC$5,127
-33.1%
2,727,0270.0%0.33%
-25.6%
DNMR  DANIMER SCIENTIFIC INC$4,812
-31.2%
821,0000.0%0.31%
-23.5%
MYPS  PLAYSTUDIOS INC$4,670
+22.8%
963,0180.0%0.30%
+36.2%
CNX  CNX RES CORP$4,615
+50.7%
222,7150.0%0.29%
+67.4%
 WAVERLEY CAPITAL ACQUIS CORPunit 99/99/9999$3,426
-1.0%
350,0000.0%0.22%
+10.1%
FSRXU  FINSERV ACQUISITION CORP IIunit 02/17/2026$3,102
-0.1%
315,0000.0%0.20%
+10.7%
PANA  PANACEA ACQUISITION CORP II$2,681
+0.5%
275,0000.0%0.17%
+11.1%
GANX  GAIN THERAPEUTICS INC$2,236
-24.7%
546,5600.0%0.14%
-16.5%
NUVB  NUVATION BIO INC$184
-38.0%
34,9950.0%0.01%
-29.4%
PSFEWS  PAYSAFE LIMITED*w exp 03/30/202$151
-20.9%
288,0000.0%0.01%
-9.1%
KPLTW  KATAPULT HOLDINGS INC*w exp 06/09/202$87
-42.0%
262,2270.0%0.01%
-33.3%
NUVBWS  NUVATION BIO INC*w exp 07/07/202$81
-57.1%
100,0000.0%0.01%
-54.5%

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

These EDGAR filings were analyzed to create this holdings report:

The EDGAR filing(s) were signed by:

  • Daniel Roitman — Chief Operating Officer

Compare quarterly holdings

Export Greenlight Capital's holdings

EDGAR filings